发明名称 Makrolidcitrat-haltige Formulierungen mit kontrollierter Freisetzung
摘要 Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also disclosed are methods for preparing, isolating and characterizing soluble and stable citrate salt of macrolides and use thereof in all solid dosage forms of macrolides.
申请公布号 DE60203461(D1) 申请公布日期 2005.05.04
申请号 DE2002603461 申请日期 2002.10.01
申请人 IND-SWIFT LTD., CHANDIGARH 发明人 WADHWA, HARDEEP
分类号 C07H17/08;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/30;A61K9/36;A61K9/48;A61K31/4745;A61K31/70;A61K31/7048;A61K47/00;A61K47/10;A61K47/26;A61K47/30;A61K47/32;A61K47/38;A61P31/00;A61P31/04;(IPC1-7):A61K31/704 主分类号 C07H17/08
代理机构 代理人
主权项
地址